Health Insurance Law Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Insurance Law Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Emory University, U.S.

Coronary artery bypass is superior to drug-eluting stents in multivessel coronary artery disease

According to a recent report from the United States, "Percutaneous intervention for the treatment of multivessel coronary artery disease continues to displace coronary artery bypass graft surgery. But controlled trials of percutaneous intervention versus coronary bypass, in meta-analysis, have shown a significant survival advantage for coronary bypass."

R.A. Guyton at Emory University wrote, "Studies of bare metal stents have not presented any data to prompt reversal of this conclusion for all but the small portion of patients most suited for...

• View Other Issues of Health Insurance Law Weekly
  
• View Other NewsRx Publications